GSK Sp ADR (GSK)
$38.65
1.01 (2.60%)
GSK Stock Quote Delayed 30 Minutes
GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q2 2024
GSK stock results show that GSK beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$37.87
Market Cap
162.39B
PE Ratio
62.13
EPS
0.622
Volume (Avg. Vol.)
3.72M
Day's Range
$37.17 - $37.72
52-Week Range
$31.37 - $44.37
Dividend & Yield
$1.55 (4.02%)
GSK Stock Predictions, Articles, and GSK Sp ADR News
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
Investors in GlaxoSmithKline are seeing a lot of red on their screens today, as GSK stock falls more than 8% on big legal news.
GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024
GSK stock results show that GSK beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs
Next gen biotech stocks such as Pfizer, Exscientia, and GSK leverage AI to drive biotech breakthroughs, shaping the future of the industry.
3 Healthcare Stocks Getting Help From the Aging Population
America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.
3 Top Dividend Stock Picks for Steady Income and Capital Appreciation
Conservative investors will benefit from these top dividend stock picks that are likely to generate significant returns.
3 Deeply Undervalued Growth Stocks to Buy in November
One of the New York Yankees' most well-known players', Yogi Berra, famous for his strange, yet funny statements, used to say, "This is deja vu…
